CROSSLINKING IMMUNOGENETICS TO PHARMACOGENETICS: FC gamma RIIIA POLYMORPHISM PREDICTS RESPONSE TO RITUXIMAB THERAPY IN MANTLE CELL LYMPHOMA
- Resource Type
- Journal
- Source
HUMAN IMMUNOLOGY ; 2016, 77 p114-p114, 1p. Supplement: 1- Subject
- Language
- English
- ISSN
- 18791166